Chimeric Therapeutics is trading 5.6% up at A$0.04 as buyers step in following recent share price weakness.
- The move is described as bargain hunting following a pullback from around A$0.05 in prior sessions.
- No new company-specific announcements or fundamental news have been released today to drive the rebound.